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Abstract
Genetic variation contributes to host responses and outcomes following infection by influenza A virus or other viral
infections. Yet narrow windows of disease symptoms and confounding environmental factors have made it difficult to
identify polymorphic genes that contribute to differential disease outcomes in human populations. Therefore, to control for
these confounding environmental variables in a system that models the levels of genetic diversity found in outbred
populations such as humans, we used incipient lines of the highly genetically diverse Collaborative Cross (CC) recombinant
inbred (RI) panel (the pre-CC population) to study how genetic variation impacts influenza associated disease across a
genetically diverse population. A wide range of variation in influenza disease related phenotypes including virus replication,
virus-induced inflammation, and weight loss was observed. Many of the disease associated phenotypes were correlated,
with viral replication and virus-induced inflammation being predictors of virus-induced weight loss. Despite these
correlations, pre-CC mice with unique and novel disease phenotype combinations were observed. We also identified sets of
transcripts (modules) that were correlated with aspects of disease. In order to identify how host genetic polymorphisms
contribute to the observed variation in disease, we conducted quantitative trait loci (QTL) mapping. We identified several
QTL contributing to specific aspects of the host response including virus-induced weight loss, titer, pulmonary edema,
neutrophil recruitment to the airways, and transcriptional expression. Existing whole-genome sequence data was applied to
identify high priority candidate genes within QTL regions. A key host response QTL was located at the site of the known
anti-influenza Mx1 gene. We sequenced the coding regions of Mx1 in the eight CC founder strains, and identified a novel
Mx1 allele that showed reduced ability to inhibit viral replication, while maintaining protection from weight loss.
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Introduction
Influenza A virus (IAV) (orthomyxoviridae) is a negative sense RNA
virus which causes severe, acute respiratory disease. Worldwide
influenza infections cause several million cases annually, with
severe pandemics (such as the 1918 pandemic) causing high levels
of morbidity and mortality [1]. Among infected individuals there is
significant variation in the clinical disease caused by IAV ranging
from an asymptomatic infection to severe and acute respiratory
distress syndrome [2–8]. Population-wide disease variation applies
not only to clinical disease, but also to individual immune
responses mounted in response to IAV infection [9,10], as well as
long-term complicating pathologies and co-infections [2,11–13].
Despite the importance of understanding the underlying mecha-
nisms of IAV-associated disease, the sources of the observed
disease variation are unclear.
Like many viruses, IAV engages in a large number of complex
interactions with various host proteins [14,15]. It is less clear how
polymorphisms in these and other host genes/proteins cause
variation in the disease process following infection with IAV. A
study of survival data from the 1918 IAV pandemic showed that
host genetic variation [16] contributes to IAV disease variation.
However, in contrast with other pathogens [17–21], human
polymorphisms have not yet been identified that contribute to
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variable responses to IAV infection, although there have been
some suggestions of polymorphisms in HLA contributing to IAV
recovery [22,23]. As IAV disease severity is likely due to a
combination of viral, host, demographic and environmental
factors [7,13,24–26], this complexity has interfered with reduc-
tionist approaches to evaluating the role that host genetic variation
plays in regulating different IAV-associated disease outcomes
across the population.
Mouse models of IAV infection have provided novel insights
into the role of host genetics on IAV disease outcomes. This
approach led to the discovery of the naturally polymorphic,
interferon inducible Mx1 gene, which inhibits IAV replication and
limits disease [27]. Subsequently, most studies of host genetic
contributions have used naturally defective Mx1 mouse strains,
such as C57BL/6J to study the effect of gene knock-outs on the
host response to influenza. These studies have shown that many
genes contribute to the host response [28–35] (reviewed in
[36,37]), and knock-outs often affect clinical disease primarily by
altering the host inflammatory response [28,29,32,35,38–40].
Comparisons between inbred mouse strains [41–44] have
confirmed that natural variation contributes to differential host
responses. Given that most polymorphisms within the human
population will be those that alter expression and/or function,
rather than whole gene knock-outs, studies comparing naturally
occurring polymorphisms are more relevant to human disease.
Several recent studies [42,45,46] using classical recombinant
inbred (RI) panels have identified a number of quantitative trait
loci (QTL) contributing to host responses following IAV infection.
However, traditional mouse genetics systems have limitations on
their ability to accurately model the genetic structure and diversity
of outbred populations, like humans [47,48].
We developed a new model that captures host responses to IAV
infection across a genetically diverse host population by using
incipient lines from the Collaborative Cross (CC) octo-parental RI
panel, known as the pre-CC population [49–51]. This population
is highly genetically diverse (,40 million single nucleotide
polymorphisms (SNPs) evenly distributed across the genome),
with up to eight functionally variant alleles at any given locus [52].
The pre-CC population exhibited a broad range of phenotypic
outcomes, including unique combinations of disease phenotypes
following infection, and we identified three novel QTL associated
with multiple aspects of influenza induced disease. Furthermore,
we identified a novel Mx1 allele in the CAST/EiJ mouse strain
and sequenced the associated haplotype. By integrating QTL
mapping with whole genome sequence information, we signifi-
cantly reduced the number of candidate genes within each QTL.
Our findings provide a clarification of the importance of genetic
variation in the host’s response to IAV infection, and a foundation
of support for the hypothesis that genetically complex mouse
models such as the CC will provide a robust platform for studying
the role of host genetic variation in regulating the host response to
infection.
Results
Diverse IAV-associated phenotypic and transcriptome
variation
We used 155 pre-CC mice, each from an independent, incipient
CC line, as well as sets of mice (n=5–11) from each of the eight
CC founder strains. Mice were infected with a dose of the mouse
adapted A/PR/8/34 (PR8) IAV that was known to cause severe
disease in several of the CC founder strains (C57BL/6J, 129s1/
SvImJ, A/J), and we assessed IAV-induced weight loss (measured
as a percentage of starting weight) and clinical disease daily
through four days post infection (D4), at which point the mice
were euthanized and lung tissue assessed for viral replication,
virus-induced inflammation and pathology, and (pre-CC mice
only) transcriptional profiles by microarray analysis within the
lungs (Table 1, Table S1, Dataset S1). This D4 timepoint was
chosen to allow severe pathology to develop in susceptible lines,
while minimizing the animals lost in this study due to humane
Table 1. Phenotypes measured in the pre-CC and founder
strains.
Phenotype Pre-CC Founders
Clinical
Disease
D4 weight X X
D4 clinical score X X
Hemorrhage X
Gross Edema X
Viral
Replication
Log Titer X X
IHC score X
Virus-induced
inflammation
Airway inflammation X X
Airway neutrophils X
Airway monocytes X
Vascular inflammation X X
Vascular neutrophils X
Vascular monocytes X
Alveolar inflammation X X
Pathology Airway damage X X
Alveolar damage X X
Pulmonary edema X
Fibrin deposition X
Transcription D4 lung expression X
doi:10.1371/journal.ppat.1003196.t001
Author Summary
Host responses to an infectious agent are highly variable
across the human population, however, it is not entirely
clear how various factors such as pathogen dose,
demography, environment and host genetic polymor-
phisms contribute to variable host responses and infec-
tious outcomes. In this study, a new in vivo experimental
model was used that recapitulates many of the genetic
characteristics of an outbred population, such as humans.
By controlling viral dose, environment and demographic
variables, we were able to focus on the role that host
genetic variation plays in influenza virus infection. Both the
range of disease phenotypes and the combinations of sets
of disease phenotypes at 4 days post infection across this
population exhibited a large amount of diversity, reminis-
cent of the variation seen across the human population.
Multiple host genome regions were identified that
contributed to different aspects of the host response to
influenza infection. Taken together, these results empha-
size the critical role of host genetics in the response to
infectious diseases. Given the breadth of host responses
seen within this population, several new models for
unique host responses to infection were identified.
Genetic Regulation of Influenza Pathogenesis
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euthanasia conditions. We examined the weight changes and
clinical scores animals experienced through the course of this
experiment, and found that weight loss and clinical scores of
animals were highest at D4. We therefore limited our analysis of
weight and clinical scores to this timepoint. Importantly, in
analyzing the phenotypes of the pre-CC mice, we found no
evidence for effects of age, generation of inbreeding, block effects
or starting weights on gathered phenotypes, and therefore did not
include these variables in our analysis.
The infected founder strains varied significantly for all
measured phenotypes, including D4 weight, log titer, virus
induced inflammation and pathology, except for variation in
alveolar debris (p-values ranging from 0.15 to 1.3761029,
Figure 1, Table S1). Founder strains could be grouped into
susceptible (high viral titer, inflammation and weight loss) or
resistant (low viral titer, little inflammation and weight loss)
groups (Figure 1, Figure S1). As with the founders, many aspects
of IAV associated disease were correlated with each other across
the pre-CC population (correlation coefficients ranging from
20.78 to 0.78, Figure 1, Table S2), with the exception of
alveolar immune cell infiltration as well as gross edema and
hemorrhage at time of harvest, which were not strongly
correlated with the rest of the host response to infection. Pre-
CC mice often showed unique combinations of disease-
associated phenotypes (e.g. high levels of viral replication but
low inflammation and weight loss, no replication but significant
weight loss, Figures 1 and 2). Therefore, though the pre-CC
population recapitulated the range of variation within any given
phenotype (Table S1), we observed new phenotypic combina-
tions not seen in the parental lines.
The unique combinations of disease-associated phenotypes
across the pre-CC population led us to investigate the relationships
between viral replication and immune cell infiltration on weight
loss, a long standing question within the IAV field. Since the large
number of pre-CC mice we had in this study lacked the genetic
structure of the founder strains, this population was uniquely
positioned to evaluate the relationships between these disease
parameters. Both log titer and airway inflammation (the cellular
infiltrate most clearly related to infection status) were significant
predictors (p-values,2.2610216 and 1.5661029, respectively) of
D4 weight (Figure 1, Table S3). However, log titer and airway
inflammation together were significantly better predictors of D4
weight than either variable alone (based on both partial F tests and
Akaike Information Criterion (AIC), Table S3).
In addition to measuring disease associated phenotypes, we also
assessed host transcript levels within the lungs at four days post
infection. Of the 155 pre-CC mice used in this study, 99 had RNA
of sufficient quality to use for RNA microarray analysis (see GEO,
accession GSE30506 for full microarray dataset). A total of 11,700
genes passed quality control processing, and did not have a SNP
across the eight founder lines which could impact their intensity on
the array. Out of these 11,700, we identified the 6000 most
variable and interconnected genes across this population and used
weighted gene co-expression network analysis (WCGNA) to cluster
these transcripts into twelve modules, labeled A–L (Figure 3, Table
S4). Seven modules (B, D, F–I, K) were enriched for specific gene
ontology (GO) terms (Table S5), including cellular signaling
(module G), cell growth and biosynthesis (module D) and immune
responses (module K). There was little to no overlap between the
enriched categories across modules. We used the eigengene, an
idealized representation of module transcription levels for each
individual mouse, to correlate module expression levels with
disease phenotypes as eigengene expression has been used
previously to simply describe the sets of transcripts within a
module [53]. We found that eigengene values for eight of the
twelve modules (modules A–C, F, H, and J–L) were correlated
with multiple disease-related phenotypes. Modules E and G
correlated with aspects of Virus-induced inflammation and
module D correlated with D4 weight (Figure 3). These results
suggest that in this genetically diverse population severity of
influenza infection is associated with wide-scale variation in a large
number of biological processes within the lung.
Figure 1. Diverse disease-associated phenotypes across the
pre-CC population. Pre-CC mice showed a wide range of variation in
phenotypes including D4 weight (Y-axis histogram, A and B), Log titer
(X-axis histogram, A) and Airway Inflammation (X-axis histogram, B). In
addition, strong correlations existed between D4 weight and both (A)
Log titer and (B) Airway Inflammation across the pre-CC population
(black diamonds). Despite these correlations, individual pre-CC mice
showed unique combinations of disease phenotypes (e.g. low Log titer
and severe D4 weight loss) not present in the founder strains of the CC
(colored circles: A/J (n = 11) = yellow, C57BL/6J (n = 6) = grey, 129S1/
SvImJ (n = 5) = pink, NOD/ShiLtJ (n = 5) = dk. Blue, NZO/HILtJ (n = 12) = lt.
blue, CAST/EiJ (n = 5) = green, PWK/PhJ (n = 5) = red, WSB/EiJ
(n = 5) = purple).
doi:10.1371/journal.ppat.1003196.g001
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Genetic mapping reveals host genome regions
controlling IAV-induced host responses
Given the variation in disease, virologic, inflammatory, patho-
logic, and transcriptional phenotypes observed in the pre-CC
animals, we conducted QTL mapping (as in [49]) to identify host
genome regions contributing to variation in IAV-induced pheno-
types (Figures S2, S3, S4, Table 2). Previous studies [27] have
identified a large effect IAV resistance gene, Mx1, on chromosome
16, and our a priori expectation (see below) was that we would
identify a QTL over Mx1, validating our mapping approaches
within the CC. Consistent with this, we identified a highly
significant QTL on chromosome 16, HrI1 (Host response to
Influenza) that contributed to a number of these disease-associated
phenotypes (D4 weight, D4 clinical, log titer, IHC score, airway
inflammation and airway damage). HrI1 explained 41.67% of the
variation in weight loss (i.e. the adjusted R-squared for a model
with all 8 strain effects), and similar amounts of variation in other
phenotypes, and was located in a 0.71 Mb region (1.5 LOD
interval: 97500418-98213493) annotated as containing 10 genes
and one non-coding RNA, including the known anti-influenza
gene Mx1. We also conducted QTL mapping on the eigengenes of
the expression modules to identify mQTL (module QTL). Three
modules (B, C, and K) had QTL that overlapped with HrI1
(Table 2). These modules included ones enriched for a number of
cell-adhesion and morphogenesis/development transcripts (mod-
ule B) and immune system response phenotypes (module K), while
module C was not enriched for any specific functional categories.
We grouped the eight founder alleles at HrI1 by their estimated
effects on each phenotype [49,54,55]. Alleles from five strains (A/
J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ and WSB/EiJ) affected
the host response similarly and were associated with decreased
influenza resistance (i.e. higher titers, higher weight loss, more
pathology), increased module K and decreased expression of
modules B and C. A/J, C57BL/6J and WSB/EiJ had previously
been identified [27,56] as having nonfunctional Mx1 alleles. In
contrast, the NZO/HILtJ and PWK/PhJ alleles within the pre-
CC population shared similar effects and increased influenza
resistance. Previously, CAST/EiJ was characterized as having a
full length Mx1 allele, based on analysis of portions of the Mx1
locus [56]. Despite the presence of a full length transcript, the
effect of the CAST/EiJ allele across the pre-CC population was
intermediate in conferring resistance in our QTL models. Pre-CC
mice with the CAST/EiJ allele showed low-to-intermediate weight
loss. In contrast, these animals had viral titers that were
intermediate between animals with nonfunctional Mx1 alleles
and those with a NZO/HILtJ or PWK/PhJ allele (Figure 4).
These three functional groups held true when considering animals
from the eight founder strains. Importantly, animals from the
CAST/EiJ strain showed intermediate weight loss, but had viral
titers no different than founder strains with nonfunctional Mx1
alleles (Figure 1). We conclude that three Mx1 alleles segregate in
the pre-CC population, with the CAST/EiJ allele being function-
ally distinct from the classical protective Mx1 allele, where this
allele confers limited protection from viral replication, but does
protect from virus-induced weight loss. We found no significant
differences in Mx1 mRNA gene expression in the lung at two days
post-infection using one strain from each allele group (C57BL/6J,
CAST/EiJ and PWK/PhJ, Figure 4). C57BL/6J had the highest
mean level of up-regulation, with CAST/EiJ intermediate and
PWK/PhJ having the lowest level of expression. This suggests that
the differences between the CAST/EiJ and PWK/PhJ alleles are
due to coding changes within the gene and not variation in gene
expression.
The sequence variation at the Mx1 locus in mouse is poorly
understood despite its well-known role in influenza susceptibility.
This is due in part to the presence of a deletion in the C57BL/6J
strain (the mouse reference genome, see Materials and Methods)
and the subsequent effect on the annotation of several of Mx1
exons in the mouse assembly (mm9) and in the Sanger Institute’s
Mouse Genomes sequencing project [57]. Therefore, we identified
the genetic variants in all Mx1 exons in each of the eight founder
strains by sequencing the Mx1 exons from each strain (see
Methods). We found five distinct haplotypes (Figure 4, Table S6).
The most common haplotype in the CC contains a large (.2 kb)
deletion that spans three coding exons (9, 10, and 11) that are
highly conserved among placental mammals. As previously
described [27], this deletion leads to a frame shift and early stop
codon in exon 12. This haplotype results in the presence of the
same non-functional Mx1 gene in A/J, C57BL/6J, 129S1/SvImJ
and NOD/ShiLtJ. We confirmed that WSB/EiJ also has a non-
functional allele due to a nonsense mutation in exon 10 [56]. The
other three strains have full length ORFs and each has a distinct
protein sequence due to the different combinations of alleles at two
non-synonymous SNPs. However, the genetic variants identified in
Figure 2. Diverse disease pathologies present across the pre-
CC population. Histopathological examination of lung sections
following IAV infection showed a diverse range of phenotypes. Each
image is a single 1006magnification image of the lung section of a
single pre-CC mouse (strain ID, D4 weight, and log titer (BDL=below
detectable limit) are listed over each image). Disease phenotypes were
scored for aspects of the damage to, and inflammatory cell infiltration
around the airways (A), inflammatory cell infiltration around the
vasculature (B), and damage and inflammatory cell infiltration in the
alveolar spaces (C). Note that the image of OR219 shows a relatively
healthy looking lung, and is useful as a baseline image.
doi:10.1371/journal.ppat.1003196.g002
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our analysis and the regional assignment of sub-specific origin
[47,58] demonstrate that the CAST/EiJ strain has a divergent
haplotype of Mus musculus castaneus origin while PWK/PhJ and
NZO/HILtJ both have haplotypes of M. m. musculus origin. The
three functional haplotypes are characterized largely by synony-
mous variation and variation in untranslated regions of the gene.
There was a single amino acid substitution identified in NZO/
HILtJ relative to PWK/PhJ and CAST/EiJ (Gly616Arg), and a
single amino acid substitution identified in CAST/EiJ relative to
NZO/HILtJ and PWK/PhJ (Gly83Arg). Although we cannot
preclude transcriptional differences at different time points during
infection from having a role in the functional differences between
the three Mx1 alleles, the nonsynonymous substitution that is
unique to the CAST/EiJ haplotypes is a strong candidate to
explain the intermediate phenotype of the CAST/EiJ Mx1 allele.
These results demonstrate our ability to identify: 1) a known IAV
resistance locus with only one mouse per line, 2) the multiple
phenotypes regulated by this locus, and 3) previously unidentified
allelic variants due to the multiple alleles segregating within the
pre-CC population.
We returned to our transcriptional data in an attempt to better
understand how the CAST/EiJ Mx1 allele could contribute to
protection from weight loss while showing high titers and severe
inflammatory responses. Of the 11,700 transcripts that passed
QA/QC and were not SNP impacted, we determined that 2156
transcripts (18.4%) had their expression levels significantly
impacted by genotype at the most significant Mx1 marker (i.e.
these transcripts had an expression, or eQTL at Mx1, Table S7),
confirming the large role that Mx1 has on regulating the response
to IAV infection. We grouped these transcripts based on their
allele effects, specifically looking for those transcripts where (a)
CAST/EiJ Mx1 alleles grouped with the resistant PWK/PhJ or
NZO/HILtJ Mx1 alleles, or (b) where CAST/EiJ allele grouped
with susceptible A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ and
WSB/EiJ Mx1 alleles. A total of 307 transcripts with an eQTL at
Mx1 (14.2%) had allele effects consistent with CAST/EiJ grouping
with the resistant PWK/PhJ and NZO/HILtJ alleles, while 1207
transcripts with an eQTL at Mx1 (55.9%) had allele effects
consistent with CAST/EiJ grouping with the susceptible A/J,
C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ and WSB/EiJ alleles.
Those transcripts where CAST/EiJ grouped with the suscep-
tible alleles showed significant enrichments for a large number of
Figure 3. Transcriptional Modules across the pre-CC population. (A) highly variable transcripts from across the pre-CC population were
grouped into modules (sets of transcripts that are connected and similarly expressed (shown here by heat map intensity) within individuals). Modules
are given colored bars below them for visual clarity. (B) Modules were correlated with different disease phenotypes.
doi:10.1371/journal.ppat.1003196.g003
Table 2. QTL identified in the pre-CC population.
QTL Phenotypes
Location
(Megabases)
HrI1 D4 weight 16:97.5–98.2
Log titer
IHC score
D4 clinical
Airway inflammation
Airway damage
Module B
Module C
Module K
HrI2 D4 weight 7:89.1–96.7
HrI3 Pulmonary edema 1:21.7–29.0
HrI4 Airway neutrophils 15:77.4–86.6
doi:10.1371/journal.ppat.1003196.t002
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GO terms (Table S8), including biosynthesis and biogenesis
processes (upregulated in the lines with a PWK/PhJ or NZO/
HILtJ allele) and a highly diverse array of inflammatory,
apoptotic, chemotactic, cell growth and hematologic-based terms
(upregulated in the lines with A/J, C57BL/6J, 129S1/SvImJ,
NOD/ShiLtJ, CAST/EiJ and WSB/EiJ alleles). In contrast, those
transcripts where CAST/EiJ was grouped with the resistant
PWK/PhJ and NZO/HILtJ alleles showed a much more limited
enrichment, with mainly cytokine and T-cell processes (downreg-
ulated in lines with CAST/EiJ, PWK/PhJ and NZO/HILtJ
alleles) being enriched.
Despite the large effect of Mx1 on influenza response, there
was large phenotypic variation within both the functional and
non-functional Mx1 allele classes. This suggested the presence
of modifier alleles segregating in the pre-CC population. To
find these modifiers, we conducted additional genome scans
after accounting for genotype at the most significant HrI1
marker (see methods), thereby controlling for Mx1 allele. This
model accounted for the large effect of HrI1 and resulted in a
single significant QTL, HrI2, on chromosome 7 (1.5 LOD
interval: 89130587-96764352), that explained 9.7% of the
variation in D4 weight (Figure S2). This region is annotated as
containing 69 genes and 10 non-coding RNAs. Analysis of the
allelic effects at HrI2 suggests that animals with an A/J allele
showed less weight loss than other animals, and animals with a
129S1/SvImJ allele showed more weight loss than other
animals.
Unique alleles contribute to disease phenotypes in a
susceptible sub-population
To eliminate epistatic effects of the protective Mx1 genotype, we
analyzed those Mx1-/- individuals in our pre-CC population,
where this group consisted of 99 mice defined as having two Mx1
alleles coming from any of the A/J, C57BL6/J, 129S1/SvImJ,
NOD/ShiLtJ or WSB/EiJ strains. Although this susceptible
subpopulation still showed a wide range of phenotypes (Table
S9), it was skewed towards increased disease-associated pheno-
types. The correlations between weight loss, viral replication,
pathology and aspects of the immune cell infiltrate were weaker
than those seen across the whole population (Table S10).
Specifically, while aspects of pathology and immune cell infiltrate
remained correlated with each other, we observed reduced
correlations between titer and pathology, titer and inflammation,
and clinical disease and pathology. We also reexamined the
relationship between titer, airway inflammation and weight loss, to
determine if our earlier observation, which linked both titer and
airway inflammation as significant predictors of weight loss was
independent of Mx1 status. Despite the reduced strength of
relationships across the population, both titer and airway
inflammation were still significant predictors of weight loss. Again,
knowledge of both titer and airway inflammation was a better
predictor of weight loss than either variable alone (based on both
partial F tests and AIC, Table S3).
RNA of high quality was recovered from 60 mice within this
Mx1-/- population, and we used WCGNA to cluster the 6,000
Figure 4. A novel Mx1 allele differentially impacts host response to influenza. The founder strain alleles at Mx1 were grouped based on
their phenotypic effects into three functionally distinct classes corresponding to domesticus (dom: A/J, C57BL6/J, 129s1/SvImJ, NOD/HiLtJ and WSB/
EiJ), castaneus (cast: CAST/EiJ) andmusculus (mus: PWK/PhJ and NZO/ShILtJ). Points shown are individual pre-CC animals with these haplotypes, mean
bars are shown for each class. These functionally distinct classes were separable based upon differences in (A) D4 weight and (B) Log titer, with the
heterozygous classes showing intermediate phenotypes. Across the pre-CC population, homozygous dom animals had severe weight loss and high
titers. Homozygous mus animals showed little weight loss and low titers. Homozygous cast animals showed little weight loss, but had intermediate
viral titers. Brackets between groups represent significant differences (* = p,0.05, ** = p,0.003) based on Tukey’s HSD. We found no difference by
qPCR (C) in expression of Mx1 at 2 days post-infection following influenza infection in a strain from each of these three functional classes. By
sequencing Mx1 (D), we were able to identify five haplotypes across the eight founder strains (Haplotype 1 =A/J, C57BL/6J, 129S1/SvImJ, NOD/HiLtJ;
Haplotype 2 =WSB/EiJ; Haplotype 3 = PWK/PhJ; Haplotype 4 =NZO/HiLtJ; Haplotype 5 =CAST/EiJ). Arrows indicate locations of polymorphisms, with
small arrows indicating non-coding changes, and large arrows indicating coding changes. Colors correspond to the founder strains having those
polymorphisms (brown=multiple strains possess mutation). Grey exons indicate those not transcribed due to either deletion and frameshift, or
insertion and early stop codon.
doi:10.1371/journal.ppat.1003196.g004
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most variable transcripts across this population (4,933 of these
6,000 transcripts were also identified in the whole population
analysis). Even in the absence of a large effect resistance gene,
Mx1, we were able to group transcripts into functionally relevant
co-expression modules. In total, this analysis identified eleven
modules labeled M-W (Table S11). Again, modules were enriched
for a wide range of functional terms, and showed little overlap
between categories (Table S12). Eight modules (M-O, Q, T-W)
were significantly correlated with clinical disease and/or viral
replication, being enriched for T-cell processes (module M),
inflammatory responses (module N), and signaling processes
(module O). Module Q (enriched for cell cycle processes) was
exclusively associated with some virus-induced inflammation, and
two modules had no clear relationships with any phenotypes
(enriched for sensory and neurological processes (module U) as
well as metabolic and biosynthesis (module V), Table S13).
Absence of an mQTL overlapping the Mx1 region (see below)
indicates that, as expected, the effect of the Mx1 locus on the
coexpression network has been ameliorated in this population.
This indicates, along with the continued, albeit, weaker associa-
tions between the modules and phenotypes that performing a
WGCNA analysis conditioning on the Mx1 allele group provides a
way to highlight additional diseases-associated genetic regulation
of transcript expression.
When we conducted QTL mapping in the Mx1-/- subpopula-
tion, we identified a significant QTL, HrI3, which explained
29.73% of the variation in Pulmonary Edema on chromosome 1
(7.31 Mb, 21767867-29085401) annotated as containing 24 genes
and 11 non-coding RNA (Table 2, Figure S3). Additionally, we
identified a suggestive QTL, HrI4, which explained 22.77% of the
variation in airway neutrophils on chromosome 15 (77427235-
86625488), a 9.19 Mb region annotated as containing 206 genes
and 35 non-coding RNAs (Table 2, Figure S4). In contrast to our
results with the whole pre-CC population, we were not able to
identify any mQTL contributing to variation in module expression
within this Mx1-/- subpopulation.
Genetic variation underneath HrI3 contributes to
pulmonary edema
In order to confirm the role of HrI3 in contributing to control of
pulmonary edema, we challenged a new set of female animals
from a small set of completely inbred CC lines with IAV. These
animals were homozygous for various founder alleles across the
entire candidate region for HrI3 and founder strain alleles were
each represented by two CC lines (e.g. two lines that vary across
the rest of their genome both share the WSB/EiJ allele at HrI3).
We examined the severity of pulmonary edema in these animals at
four days post infection. Founder strain alleles at HrI3 significantly
affected pulmonary edema (F3,16 = 8.48, p = 0.0013, Figure 5),
validating the role of this genome region in the host response to
IAV.
Identification of candidate genes from whole-genome
sequences
Having identified three novel QTL our next objective was to
narrow down QTL regions to specific candidate genes/features.
We used the estimated allele effects along with the whole genome
sequences of the founder strains [57] to narrow the list of
candidate genes within each interval (see methods).
When a particular allele underlies a QTL, it is due to a causal
genome feature (e.g. SNP, insertion/deletion) corresponding to
that allele, contrasted with the other alleles in the cross. In the
simplest case of one allele contrasted with the other seven this
means that a private genome feature in the single strain is
causative for the QTL. Under more complex scenarios (e.g. two
strains contrasted with six), because CC mice share common
ancestry due to their natural history and the unique history of
laboratory mice [47,58], we assume that causal alleles are often
shared across mouse strains. That is, if two strains are segregating
from the other six, it is likely due to a common feature these two
strains privately share. We used the allele effects plots (Figures S2,
S3, S4) to group founder strains underneath QTL peaks into two
groups based on the largest difference between groups (Note that
for completely inbred lines, phenotype-by-genotype plots would
provide similar information. For the incompletely inbred pre-CC
mice, with up to 36 allele combinations at each locus, PxG plots
are difficult to interpret). For each group, we identified the regions
in which all strains were identical or nearly identical ($98%).
Then we excluded regions that were not unique to the allele group
(e.g. where two causative alleles had different SNP patterns). Using
this approach, we narrowed the candidate regions for HrI3
(Pulmonary Edema: NZO/HILtJ and WSB/EiJ alleles reducing
edema), from 7.31 Mb to 1.01 Mb, containing 10/24 genes and
1/10 annotated non-coding RNAs (Table 3). HrI4 (Airways
Neutrophils: C57BL6/J, NZO/HILtJ and PWK/PhJ increasing
infiltration) was similarly reduced from 9.19 Mb to 91 kb,
including 12/206 genes and 2/35 non-coding RNAs (Table 3).
HrI2 represented a case where a single founder allele associated
with either increased resistance (A/J) or susceptibility (129S1/
SvImJ) contrasted with the other six strains showing an
intermediate phenotype. We were therefore looking for individual
SNPs (and not regions of difference) that differentiated A/J or
129S1/SvImJ from the other strains. We identified 144 private A/
J SNPs or small in/dels, and 611 private 129S1/SvImJ SNPs or
small in/dels (out of a total of 106,684 SNPs or small in/dels in the
region). These SNPs occur in or near 28 genes (7 genes unique to
A/J, 13 unique to 129S1/SvImJ, and 8 overlapping between the
two, Table 3).
In all three of these cases, the high priority candidate genes we
identified covered a range of biological functions, including a large
number with no annotated functions. While no obvious candidates
jump out with HrI3, HrI4 includes Grap2, involved in leucocyte
specific signaling [59]. Similarly, HrI2 includes the chemoattrac-
tant/T-cell modulator Il16 [60] as well as Nox4, which is
potentially involved in production of reactive oxygen species and
interacts with the TLR4 pathway [61].
Discussion
The host response to infection represents a complex set of
interacting phenotypes, where variation in these phenotypes is
likely influenced by interactions between multiple polymorphic
genes as well as other factors (specific virus-host interactions,
environment, exposure, age). While reverse genetics approaches
have afforded insight into the role of viral genes in infection [62–
64], well defined models do not exist for understanding how
polymorphic host genes interact to regulate host response to
infection. A number of mouse models including gene specific
knockouts and transgenic lines [28–30,32,34,35,39,65], panels of
genetically distinct mouse lines [44,66], and classical RI panels
[42,45,46], have been used to provide key insights into the role of
specific genes in pathogenesis, however, these systems do not
accurately reflect the situation in outbred populations. While these
systems either interrogate the role of specific genes in the context
of a single genetic background (e.g. knockouts) or analyze the
impact of two variant alleles (e.g. classic RI panels) on disease
pathogenesis, in genetically complex populations, such as humans,
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disease outcomes are likely determined by interactions between
multiple polymorphic genes, with multiple polymorphic alleles at
these loci. Therefore, we chose to use the pre-CC population to
assess how genetic polymorphisms impact the host response to
influenza infection in a population of animals that more closely
represents the genetic diversity found in outbred populations. Our
results show that even within the constraints of this pre-CC study
(i.e. one animal/incipient line, single time point), we were able to
uncover underlying relationships between host responses to
infection, identify new disease phenotype combinations not
present within the founder strains, and identify novel QTL
impacting aspects of the host response to infection, suggesting that
the CC panel represents a powerful system for studying pathogen
interactions within genetically complex populations.
Host genetic control of infectious disease responses
Host genetic polymorphisms have been shown to contribute to
differential disease outcomes, and evidence exists for influenza
[16,22,23,67] that suggests host genetic variants are important
regulators of influenza pathogenesis. The identification of a QTL
of major effect sitting over the anti-influenza gene Mx1 was not
surprising. Mx1 is known to strongly inhibit influenza virus
replication, limiting the resultant IAV-induced disease symptoms
in mice [68]. As was to be expected, within the pre-CC
population, functional Mx1 alleles reduced viral titers, weight loss
and clinical disease, inflammation and pathology. Mx1 also acted
to influence the expression levels of a large number of transcripts.
While it is unlikely a direct transcriptional regulator, Mx1’s potent
ability to inhibit IAV replication likely alters the signaling
environments and host response pathways triggered in response
to infection.
Within human populations, it is possible for multiple alleles to
exist at any given locus. Similarly, at any locus within the pre-CC
population, up to eight distinct alleles exist. In addition to
increasing the probability of having functionally variant alleles
Figure 5. Genetic variation at HrI3 contributes to variation in pulmonary edema in an independent set of Collaborative Cross lines.
Following the identification of HrI3, we infected animals from fully inbred Collaborative Cross lines, where each line was homozygous for a single
founder allele at HrI3. (A) We found a significant effect of genotype at HrI3 on the extent and severity of pulmonary edema at four days post infection.
Mild (B) and Severe (C) pulmonary edema can be seen at 2006magnification in animals from this experiment. Pulmonary edema was scored on the
basis of evidence of transudates accumulating in the alveolar spaces (denoted by star marks in panel C).
doi:10.1371/journal.ppat.1003196.g005
Table 3. Candidate genes within QTL regions.
HrI2 HrI3 HrI4
9930013L23Rik
(A)
Vmn2r73 (A) 4931308C20Rik Atxn10
AC139576.1 (A) 1700026D08Rik (C) Bai3 AW121686
AC156557.1 AC099601.2 (C) Col19a1 Cacng2
AdamTsl3 (A) AC111022.1 (C) Fam135a Card10
Ctsc (A) AC161439.1 (C) Gm5697 Cbx7
Folh1 Arnt2 (C) Gm9884 Celsr1
Grm5 Eftud1 (C) Gm11161 Enthd1
Il16 Fam108c (C) Kcnq5 Grap2
Mesdc2 Fam154b (C) Rims1 Lgals2
Nox4 Mex3b (C) Smap1 Mirlet7c-2
Sh3gl3 Olfr301 (C) SNORA17 Pdgfb
Tmc3 Tmem135 (C) Sstr3
Tyr (A) Vmn2r72.ps (C) Syngr1
Vmn2r66 (A) zfand6 (C)
For HrI2, (A) refers to genes with a private A/J SNP, (C) refers to genes with a
private 129S1/SvImJ SNP. Unmarked genes had both A/J and 129S1/SvImJ
SNPs.
doi:10.1371/journal.ppat.1003196.t003
Genetic Regulation of Influenza Pathogenesis
PLOS Pathogens | www.plospathogens.org 8 February 2013 | Volume 9 | Issue 2 | e1003196
segregating within the population, multiple alleles at a locus can
give rise to distinct phenotypic outcomes across the population.
The effects of this allelic variation can clearly be seen when
considering Mx1. A total of 5 distinct Mx1 haplotypes exist in the
pre-CC population, and they can be grouped into three
functionally distinct alleles based on their effects during influenza
infection. Of particular interest is the CAST/EiJ allele, which
disassociates the effects of Mx1 on control of viral replication from
its’ ability to protect from a clinical disease aspects. We utilized the
large number of transcripts that had an eQTL at Mx1 to better
understand potential ways in which the CAST/EiJ allele might
provide clinical protection while being unable to control IAV
replication. We identified a set of transcripts that were significantly
upregulated in those individuals with defective Mx1s, but were
downregulated in individuals with CAST/EiJ, PWK/PhJ and
NZO/HILtJ Mx1 allele). These transcripts included sets of
inflammatory and immune related transcripts, such as SOCS3,
Irf1, and Interferon-gamma. GTPases, such as Mx1, are important in
a number of signaling and protein production activities [69,70],
and it is possible that the signaling activities of Mx1 are responsible
for regulating specific transcripts, such as those mentioned above,
in limiting clinical disease independent of Mx1’s previously
described anti-IAV activities. However, additional studies are
needed to better define whether the differential effect of the
CAST/EiJ Mx1 allele are due toMx1-associated signaling or more
subtle effects on viral replication which subsequently affect
inflammation and disease.
In a more general sense, these results illustrate the advantages
provided by using a system such as the CC compared to using
classical inbred strains such as the founder strains. Because of the
inherent genome structure of the founder strains [47], it would be
difficult to differentiate between the disassociated effects of the
CAST/EiJ Mx1 allele we found in the pre-CC population and the
alternate hypothesis that CAST/EiJ’s Mx1 was completely non-
functional, and that there was another polymorphic gene within
CAST/EiJ that provided some protection from clinical disease. It
is only through the recombination present within the CC, and the
use of large populations of unique lines that can be evaluated
within the CC that such hypothesis can be differentiated. This lack
of structure across the genomes also allowed us to gain new insight
into the relationships between coexpressed transcripts and disease
outcomes, as well as the relationships between specific disease
processes (see population-wide pattern section below).
Though the identification of Mx1 served to validate our
mapping study, the presence of a large effect allele within
genetically variable populations can mask those with smaller effect
sizes. Indeed, this genetic architecture is common to pathogen
resistance, as several other large effect genes have been identified
for viral (e.g. flaviviruses [71], mouse CMV [72], norovirus [20],
HIV [18]), bacterial (NRAMP [73]) and parasitic (malaria [74])
diseases. Due to these genes of large effect, many studies of these
pathogens have been conducted within susceptible models (e.g.
mouse models of influenza infection are almost universally Mx1-/-
models). It is likely that there are specific alleles influencing disease
processes that only act in the context of the presence or absence of
major resistance alleles (e.g. an allele that affected the degree of
tissue repair would only act when there had been significant tissue
damage, which a functional Mx1 allele would prevent). To address
this issue, we conducted further genome mapping while account-
ing for Mx1 status using two complementary approaches: asking
whether there are loci that act in addition to Mx1 in regulating
disease-associated phenotypes (HrI2), and also asking if there are
loci that act only in the highly susceptible Mx1 negative population
(HrI3, HrI4). By doing so, we were able to identify three additional
loci influencing weight loss, pulmonary edema and neutrophil
infiltration into the airways, further validating the role of genetic
variation at HrI3 in contributing to pulmonary edema differences
in a separate set of fully inbred CC animals. The development of
pulmonary edema [6,75], as well as neutrophilic infiltration [76]
have been shown to contribute to disease severity and long-term
lung disease in the human population. Our results show that host
genetic variation not only contributes to direct responses to
infection, but also to other aspects of the host response that can
lead to long-term complications following infection.
In addition to allowing us to identify novel QTL that impacted
the host response to IAV, our mapping using only Mx1-/- animals
also allowed us to compare our study to other studies using QTL
mapping within Mx1-/- panels [42,45,46]. While these studies all
identified QTL contributing to IAV responses, there was no
overlap between these QTL and the ones we discovered. This
result is unsurprising given the differences in virus strains,
phenotypes measured, and polymorphisms within the two panels.
Nevertheless, the aggregate of these studies further strengthens the
idea that virus-host interactions are highly complex, and that
polymorphic host genes are critical for numerous responses. Our
results further emphasize the unique genetic interactions that
occur in specific sub-populations of infected individuals that
regulate disease processes. While we limited our analysis to the
Mx1-/- animals in the pre-CC population, due to sample size, it is
likely that similar QTL can be identified in future work using
animals with functional Mx1.
Ultimately, the goal of QTL mapping studies is to identify the
causal polymorphic genes or genome features responsible for
variation in disease processes. A variety of studies have used
transcriptional data [42,49] to narrow QTL regions into candidate
genes. However, transcriptional analysis can be confounded by the
dynamic nature of transcriptional responses, and can also be
confounded by SNPs residing underneath the expression probes
that can impact binding [77,78]. An alternate approach, taking
advantage of the allelic complexity of the CC is the use of the
sequence of the founder strains [57] to interpret the mapping
results and to prioritize candidate genes within QTL. This
approach is quite powerful; as causative polymorphisms must be
contained within QTL regions, and has been used effectively in
other pre-CC studies [49,55]. However, Mx1 provides a caution-
ary note for regions of the genome in that there is a large in/del
differentiating the eight CC founders. In fact, C57BL/6J, and thus
the assembly, has the deletion. In such regions, functional genomic
features may be misannotated and more importantly the genetic
variants present in founders without the deletion is currently not
annotated. This lack of annotation makes it difficult to conclusively
dissect the polymorphisms within these regions that might cause
phenotypic variation across the population, and currently requires
more intensive sequencing efforts on a case-by-case basis. The
Mx1 result illustrates the importance of improving the annotation
of genetic variants in the mouse genome. It also suggests that in
addition of the processed lists of SNPs and in/dels available at the
Mouse Genome Projects from the Sanger Institute, the analysis of
the allele effect in QTL intervals should be analyzed by searching
for signatures of structural variation that might be present in the
raw reads. As further QTL analyses are undertaken within the CC
system, approaches to narrow down onto candidate genes and
polymorphisms will need to be further developed, likely integrating
both transcriptional and refined analysis of sequence data to
account for other potential causative genome features. These
approaches will be facilitated by the interrogation of transcrip-
tional activity at multiple time points in completely inbred CC
lines.
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Population-wide patterns of host response to influenza
infection
The pre-CC experiment also allowed us to identify specific CC
lines that might be useful models for specific disease phenotypes
(e.g. animals with high titers but little/no clinical disease as super-
spreaders), as well as other interesting relationships between
disease components across the pre-CC population. For example,
while lung hemorrhage is a clinically important influenza-
associated phenotype [79], we found that lung hemorrhage was
only correlated with alveolar inflammation and not with other
metrics of viral spread or disease severity. This result bears further
study, but it suggests that while hemorrhage indicates a severe
response to influenza infection, hemorrhage is governed by
processes that are largely disassociated from those processes
contributing to overall severity of infection at least through day 4.
Results such as this further highlight the complexity of the host
response to infection, and the need to consider genetically diverse
populations when attempting to understand disease processes.
While the individual pre-CC mice used within this study were
insufficient to develop these new models of disease processes, as
CC lines become increasingly available [52], utilization of specific
CC lines with unique responses to infectious diseases might well
become a critical resource for uncovering avenues of viral
pathogenesis in specific subpopulations.
In addition, we identified transcriptional modules that corre-
lated with overall disease severity, or with specific aspects of the
host response to infection (e.g. inflammatory components, clinical
disease). Recent efforts from a number of groups [10,80] have
focused on identifying markers associated with different disease
states (e.g. protective vaccine responses, asymptomatic individu-
als) across human cohorts. While the nature of the pre-CC study
(restricted to a single time-point) makes it difficult to draw broad
conclusions about these results, it does suggest that there are
unique transcriptional signatures relating to different aspects of
the host response to infection. Future studies leveraging the full
power of the CC (identical animals at different time points,
compared to baseline transcriptional levels) will provide the
opportunity for identification of molecular signatures of different
disease-associated phenotypes, informing us both of the mecha-
nisms through which these processes are occurring, as well as
providing non-invasive diagnostic markers of various disease-
related phenotypes.
The findings of this study also provide new insights into the
relative contribution of viral replication versus virus-induced
inflammation in the pathogenesis of influenza infection. There is
conflicting evidence from a variety of in vivo studies as to the
importance of virus-induced inflammation [28,39,64,81,82] and
control of viral load [30,39,66] on disease severity. However, these
studies have all used different mouse strains, influenza strains and
experimental conditions, making direct comparisons difficult. The
novel allele combinations in the pre-CC population allowed new
insight by dissociating phenotypes that were correlated in the
founder strains. This allowed us to assess the relative contribution
of inflammation and viral replication on disease outcome.
Consistent with the complex nature of virus-induced disease, we
found that both viral replication and levels of inflammation were
predictive of disease outcome independently of one another.
Although the overall correlations between viral titer, weight loss
and inflammation were reduced within the Mx1-/- subpopulation
of pre-CC animals, we again found that both viral replication and
levels of inflammation together were better predictors of disease
outcome than either was alone. Consistent with this analysis, we
identified CC lines that showed high levels of replication and
weight loss, but little inflammation as well as lines with excessive
inflammation and weight loss, but low viral titers suggesting that
multiple pathways can lead to similar clinical disease outcomes
across a genetically diverse population. Future studies utilizing this
model with fully inbred CC lines, will allow us to more fully
evaluate how the kinetics, magnitude, and duration of viral
replication and inflammation contribute to disease outcome over
the temporal course of the infection. These results illustrate the
potential and the power of using genetically diverse mice to study
the relative contribution of specific aspects of the pathogen and
host response which together drive disease outcome.
Summary
There is an increased appreciation for the role that host
polymorphisms play in the host response to infectious diseases
[83]. However, for a number of reasons, Genome Wide
Association Studies (GWAS) of responses to acute infectious
diseases within the human population have been difficult to
conduct [84]. While future studies using the CC panel will allow
for the evaluation of multiple animals/line and allow for
integration of information across multiple timepoints, for this
study we had access to only a single animal/line within the pre-
CC population making it similar in design to GWAS and raising
concerns about our ability to identify host response QTL within
this study. However, the identification of several disease
associated QTL, including a QTL containing the known IAV
associated resistance gene Mx1, even when using a single mouse/
time point, suggests that the CC lines represent a robust system
for identifying polymorphic genes that regulate host responses to
infectious diseases. As the CC can be recreated and manipulated,
it will increasingly become a useful tool to a) identify candidate
genes and pathways for more targeted association studies within
human populations, and b) allow us to increase our understand-
ing of how critical demographic and environmental factors, as
well as specific genetic subpopulations impact some of the
variability in GWAS studies of acute infectious diseases in
humans.
Host genetic variation clearly plays an important role in
regulating differential response phenotypes to infectious disease
progression. Herein, we provide proof of concept and a
framework for identifying the role of polymorphic genes on
microbial pathogenesis using a genetically diverse population:
underlying relationships between different disease phenotypes,
genetic control of phenotypes following infection (both those of
large effect, as well as those that modulate the host response), and
transcriptional profiles that related to specific disease-associated
phenotypes. In summary, this study shows that a genetically
complex in vivo model represents a useful system for modeling
pathogen interactions within genetically diverse populations and
identifying novel genetic loci controlling multiple aspects of
disease pathogenesis. Though this study had clear limitations, the
pre-CC population provided the appropriate framework to
develop the methodological approaches that resulted in the
identification and prioritization of genes within novel disease loci.
These results strongly support the hypothesis that studies using
the fully inbred CC lines, with the use of replicate animals and
evaluation of phenotypic variation during influenza infection over
time, will be even more successful in identifying polymorphic
genes that regulate multiple disease associated phenotypes
including those phenotypes associated with adaptive immune
responses and disease recovery. Furthermore, through careful
selection of CC lines, studies can be designed to specifically
investigate how interactions between allelic variants in two or
more genes interact to influence complex phenotypic outcomes
during infection.
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Methods
Ethics statement
Mouse studies were performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
mouse studies were performed at the University of North
Carolina (Animal Welfare Assurance # A3410-01) using
protocols approved by the UNC Institutional Animal Care
and Use Committee (IACUC). All studies were performed in a
manner designed to minimize pain and suffering in infected
animals, and any animals that exhibited severe disease signs was
euthanized immediately in accordance with IACUC approved
endpoints.
Animals
8–16 week old female animals from the 8 founder strains (A/
J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, NZO/HILtJ,
CAST/EiJ, PWK/PhJ, and WSB/EiJ) were derived from the
Jackson labs (jax.org), and bred at UNC Chapel Hill under
specific pathogen free conditions. 8–12 week old female Pre-
CC mice were bred at Oak Ridge National Laboratories under
specific pathogen free conditions, and transferred directly into
a BSL-3 containment laboratory at UNC Chapel Hill. Inbred
CC mice were bred at UNC Chapel Hill under specific
pathogen free conditions. All experiments were approved by
the UNC Chapel Hill Institutional Animal Care and Use
Committee.
Virus and cell lines
The mouse adapted influenza A strain A/PR/8/34 (H1N1) was
used for all infection studies. A/PR/8/34 stocks were made by
infection of 10-day old embryonated chicken eggs. MDCK cells
grown in high glucose Dulbecco’s modified Eagle’s medium (10%
FBS, 1% Penicillin-Streptomycin) were used for titering virus.
Infections
Animals were lightly anesthetized via inhalation with Isoflurane
(Piramal, Bethlehem, Pa). Following anesthesia, animals were
infected intranasally with 5610‘2 pfu of PR8 in 50 mL of
phosphate buffered saline (PBS), while mock infected animals
received only 50 mL of PBS. Animals were assayed daily for
morbidity (determined as % weight loss), mortality and clinical
disease scores. At 4 days post infection, animals were euthanized
via Isoflurane overdose and cardiac puncture, animals were
assessed for gross pathology (lung hemorrhage and edema) and
tissues were taken for various assays.
TCID50 assay
MDCK cells were seeded into 96 well plates at a density of
1.5610‘5 cells/well in DMEM (10% FBS, 1% Pen-strep) and
incubated at 37 degrees overnight. Cells were washed 2 times with
PBS, before addition of 100 mL of DMEM to each well. Media
was removed from all wells in the 1st column of the plate, and
146 uL of lung homogenate in DMEM was added to these wells
(each biological sample was added to 4 wells). Serial dilutions of
46 mL (0.5 log dilutions) were carried out across the plate. Plates
were incubated at 37 degrees C for 1 hour, inoculum was removed
and 150 mL of serum free DMEM with 1 mg/mL of trypsin was
added to each well. Plates were then incubated at 37oC for 3 days.
Media was then removed, and wells were stained with a 1%
Crystal Violet solution. The stain was washed off with water. Titer
is determined as follows:
Log10 TCID100~2  Log10TCID50~
{2  Xpz 0:5 Dð Þ{ D  Spð Þð Þ
ð1Þ
Where Xp is the last dilution where all of the replicates of a given
sample are positive, D is the serial dilution log and Sp is the sum of
the proportion of replicates at all dilutions where positives are seen
(starting with the Xp dilution).
Histopathological analysis
The right lung was removed and submerged in 10% buffered
formalin (Fischer) without inflation for 1 week before being
submitted to the UNC Linberger Comprehensive Cancer Center
histopathology core for processing. Two 5 micron thick Hema-
toxylin and Eosin stained lung sections (step-separated by
100 microns) were blind-scored by microscopic evaluation per-
formed by two independent scorers for a variety of metrics relating
to the extent and severity of immune cell infiltration and
pathological damage on a 0–3 (none, mild, moderate, severe) scale.
Immunohistochemical analysis of viral replication
For detection of influenza virus antigen, we used serial sections
from formalin-fixed, paraffin-embedded lung samples. After
deparaffinization and rehydration, antigen retrieval was per-
formed using 0.1% protease (10 min at 37uC). Endogenous
peroxidase was blocked with 3% hydrogen peroxide and slides
were briefly washed with phosphate-buffered saline (PBS)/0.05%
Tween 20. Mouse anti- influenza virus nucleoprotein (clone Hb65,
ATCC) and horseradish peroxidase labeled goat anti-mouse
IgG2a were used for 1 h at room temperature. Peroxidase activity
was revealed by incubating slides in 3-amino-9-ethylcarbazole
(AEC, Sigma) for 10 minutes, resulting in a bright red precipitate,
followed by counterstaining with hematoxylin. Tissue sections
from non-infected BALB/c mice and mouse IgG2a isotype
antibody (R&D) were used as negative controls. The extent of
influenza viral antigen spread across these slides was then scored in
a blinded fashion on a 0–3 scale.
RNA preparation and oligonucleotide microarray
processing
At 4 days after infection, mice were killed and lung tissue
harvested and placed in RNAlater (Applied Biosystems/Ambion,
Austin, TX) and stored at 280u. The tissues were subsequently
homogenized, and RNA extracted as previously described [85].
RNA samples were spectroscopically verified for purity, and the
quality of the intact RNA was assessed using an Agilent 2100
Bioanalyzer. cRNA probes were generated from each sample by
the use of an Agilent one-color Low Input Quick Amp Labeling
Kit (Agilent Technologies, Santa Clara, CA). Individual cRNA
samples were hybridized to Agilent mouse whole-genome oligo-
nucleotide 4644 microarrays according to manufacturer instruc-
tions. Samples from individual mice were evaluated to enable
examination of animal-to-animal variation as part of the data
analysis. Slides were scanned with an Agilent DNA microarray
scanner, and the resulting images were analyzed using Agilent
Feature Extractor version 8.1.1.1. The Agilent Feature Extractor
software was used to perform image analysis, including signifi-
cance of signal and spatial detrending and to apply a universal
error model. For these hybridizations, the most conservative error
model was applied. Raw data were then loaded into a custom-
designed laboratory information management system (LIMS).
Data were warehoused in a Labkey system (Labkey, Inc., Seattle,
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WA). Raw array data are available from GEO with accession
GSE30506.
The Agilent arrays were background corrected by applying the
Normal-Exponential convolution model [86] and normalized
using quantile normalization [87] with the Agi4644PreProcess
Bioconductor package (www.bioconductor.org). The probes were
filtered requiring that all probes meet specific QC requirements
(probe intensity had to be found, well above background, not
saturated, and not be nonuniformity or population outliers as
defined by the standard parameters in Agi4644PreProcess
package) for all samples. Differential expression analysis was
performed using the LIMMA Bioconductor package [88], and the
false discovery rate was calculated using the qvalue Bioconductor
package [89]. Probes were mapped to the mm9 genome using
BLAT [90] requiring at least 98% identity. Probes that did not
map, mapped to multiple locations equally well, or contained a
high confidence single nucleotide polymorphism (SNP) from one
of the eight progenitor strains from the Sanger Institute/Wellcome
Trust mouse sequencing project [57] in the probe sequence were
excluded from analysis. There were 11,700 probes passing QC
and not potentially impacted by a SNP. The Gene Ontology (GO)
analysis was performed using the standard hypergeometric test
from the Gostats Bioconductor package [91] with a universe
consisting of the unique genes from the probes entered into the DE
analysis. Only the Biological Process subset of the Gene Ontology
was used for testing. The Benjamini and Yekutieli false discovery
rate (FDR) [92] was computed for the P-value distribution for this
analysis to address dependencies inherent from the hierarchical/
nested structure of the GO categories.
De-novo network (module) analysis
For both the full analysis and the Mx1-/- analysis, six thousand
probes were chosen to be entered into the analysis based on both
high variability across samples as well as a measure of how
connected they were [93]. Arrays were preprocessed separately for
both analyses. These probes were used for the formation of
coexpression modules through the weighted gene coexpression
network analysis (WGCNA) procedure [93,94]. Module formation
was signed [95] and was carried out using the dynamicTreeCut R
package [96] with pruning carried out based only on the
dendrogram. All modules were checked for statistical significance
through a permutation procedure whereby the mean topological
overlap of those probes within a module was compared to the
mean topological overlap of 10,000 random modules of the same
size chosen from the initial set of 6,000 probes. Using the
WGCNA package the module eigengene (first principle compo-
nent of the expression matrix) for each module was computed
[97]. The module eigengene can be viewed as the representative
profile that summarizes the module expression profile. The
module eigengene was first correlated with the clinical traits using
Pearson’s correlation with P-values provided as Student’s asymp-
totic P-value. The module QTL scan was carried out similar to
below but using the eigengene for each module as a phenotype.
Specifically, each eigengene was regressed on the expected
haplotype contribution from each of the eight founding inbred
strains. Significance was assessed using the –log10 P-values (using
a Bonferroni type correction (a=0.05)) from the model and
support intervals were computed using the 1.5 LOD drop method
[54]. This method of defining an mQTL is essentially the same as
a previous study using F2 intercrosses [53]. A related approach
looking at overrepresentation of eQTLs in a module [98] could
potentially be sensitive to significance cutoffs and module size and
necessitates a full eQTL scan.
Genotyping and haplotype reconstruction
Genotyping and haplotype reconstruction were done as
described in [49]. Briefly, each pre-CC animal was genotyped
using Mouse Diversity [47] test A-array at 181,752 well
performing SNPs which were polymorphic across the founder
strains. Once genotypes were determined (Dataset S2), founder
strain haplotype probabilities were computed for all genotyped loci
using the HAPPY algorithm [99]. Genetic map positions were
based on the integrated mouse genetic map using mouse genome
build 37 [100].
Genome scans
Genome scans were run as described in [49]. Briefly, QTL
mapping was conducted using the BAGPIPE package [101] to
regress each phenotype on the computed haplotypes in the interval
between adjacent genotype markers, producing a LOD score in
each interval to evaluate significance. Genome-wide significance
was determined by permutation test, with 250 permutations
conducted per scan.
A more complex model was also used to control for Mx1 status,
whereby the null model included the haplotype information from
the most significant marker at the Mx1 locus (JAX00072951).
LOD scores are then computed for each haplotype interval based
on the increase in fit of genotype to phenotype when Mx1
haplotype is already taken into account.
Identifying candidate regions
For the likely regions of identified QTL peaks, SNP data for the
eight founder strains from the Sanger mouse genomes project was
downloaded, and filtered to include only homozygous calls. In the
case where a single founder strain allele drives a QTL peak, all
private SNPs for that strain are candidates for the observed
phenotype. In the case where multiple founder strains drive a
QTL peak, the most likely hypothesis is that the causative
polymorphism exists in a region of shared ancestry between these
founder strains. SNPs were categorized into 3 classes: Consistent
with a shared ancestry (SNPs where the driver strains share a
private SNP), Inconsistent with a shared ancestry (SNPs where the
driver strains share different alleles with other strains), and
Uninformative with regards to ancestry (SNPs private to a single
strain and SNPs shared by driver strains as well as others).
Candidate regions were defined as regions containing at least one
consistent SNP, and were bounded by the 1st nucleotide after the
last inconsistent SNP until the last nucleotide before the next
inconsistent SNP, and also had to exceed 100 base pairs in length.
We identified all annotated genes and non-coding RNAs that were
within 500 bases of, or in consistent regions and classify these as
our likely candidates.
Mx1 gene structure
To characterize the genetic variation at the Mx1 locus we
combined data from the mouse genome assembly, the Sanger
Institute’s Mouse Genomes sequencing project and a mouse
full-length Mx1 cDNA clone (CT010406). By aligning the
cDNA to the Mx1 genomic locus we identified three missing
exons (exons 9, 10 and 11). We used this information to design
primers to amplify and sequence every exon and the span the
deletion boundaries in each strain (Table S14). The deletion
occurs between positions 97674078 and 97674079 of the
reference on chromosome 10. The deletion is 921 bp
upstream from exon 12 and 302 bp downstream of exon 8.
Chromosome walking was used to partially sequence the
introns missing in the assembly. All sequence variants have
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been submitted to NCBI (GenBank Accession numbers:
JQ860141-JQ860220).
Real-time PCR analysis
Whole lung RNA from 8 week old female C57BL/6J, CAST/
EiJ, and PWK/PhJ that had been either mock or flu infected were
isolated using Trizol (Invitrogen, Carlsbad CA), and following
their protocol. One microgram of total isolated RNA from each
sample was reverse transcribed using MMLV-RT (Promega,
Madison WI), and following their protocol. We ran TaqMan real
time PCR with two primer-probe pairs (Applied Biosystems Foster
City, CA): Mm01217999_m1 to amplify the 59 gene region of
Mx1 transcripts, and Hs03928985_g1 to amplify 18s mRNA.
Fold-induction was calculated as the difference in expression levels
for infected animals as compared to their strain-matched mock
animals.
Supporting Information
Dataset S1 Phenotypes of Pre-CC animals.
(CSV)
Dataset S2 Genotypes of Pre-CC animals.
(ZIP)
Figure S1 Variation in weight loss curves across the
eight founder strains of the Collaborative Cross.
Following infection with IAV, n= 5–12 animals from each of the
eight founder strains had their weights recorded through four days
post infection. Shown are weight loss curves (with standard
deviations) for these eight strains (A/J (n = 11) = yellow, C57BL/6J
(n = 6) = grey, 129S1/SvImJ (n= 5) = pink, NOD/ShiLtJ
(n = 5) = dk. Blue, NZO/HILtJ (n = 12) = lt. blue, CAST/EiJ
(n = 5) = green, PWK/PhJ (n= 5) = red, WSB/EiJ (n = 5) = pur-
ple).). The high variation present within NOD/ShiLtJ and CAST/
EiJ was due to bimodal weight loss responses in each strain, and
repeated in multiple experiments,
(TIF)
Figure S2 QTL underlying weight loss following influ-
enza infection. (A) QTL scans showing LOD score (Y-axis) and
genome position (X-axis) for weight loss. HrI1 on chromosome 16
(dark peak) was identified and influenced many disease phenotypes
We remapped weight loss after accounting for the large effect of
HrI1 in our QTL model, and identified another QTL, HrI2 on
chromosome 7 (light grey peak). Allele effects plot for (B) HrI1 and
(C) HrI2, showing the estimated contributions of each founder
strain allele (y-axis) across the likely region for these loci (position
in locus, x-axis) on weight loss. A phenotype by haplotype plot (D)
showing the weight loss phenotypes for those animals that were
homozygous for founder strain alleles at HrI2 (A/J = yellow,
C57BL/6J = grey, 129S1/SvImJ=pink, NOD/ShiLtJ = dk. blue,
NZO/HILtJ = lt. blue, CAST/EiJ = green, PWK/PhJ = red,
WSB/EiJ = purple).
(TIF)
Figure S3 QTL underlying pulmonary edema following
influenza infection. (A) QTL scans within the Mx1 -/-
subpopulation (light grey line) identified a QTL, HrI3 on
chromosome 1, influencing pulmonary edema that was not
detectable within the whole pre-CC population (black line). (B)
Allele effects plot for HrI3, showing the estimated contributions of
each founder strain allele across this locus on pulmonary edema. A
phenotype by haplotype plot (C) showing the pulmonary edema
score for those animals that were homozygous for founder strain
alleles at HrI3 (A/J = yellow, C57BL/6J = grey, 129S1/SvImJ=
pink, NOD/ShiLtJ = dk. blue, NZO/HILtJ = lt. blue, CAST/
EiJ = green, PWK/PhJ = red, WSB/EiJ = purple).
(TIF)
Figure S4 QTL underlying neutrophil infiltration fol-
lowing influenza infection. (A) QTL scans within the Mx1 -/-
subpopulation (light grey line) identified a QTL, HrI4 on
chromosome 15, influencing neutrophil infiltration that was not
detectable within the whole pre-CC population (black line). (B)
Allele effects plot for HrI4, showing the estimated contributions of
each founder strain allele across this locus on neutrophil
infiltration. A phenotype by haplotype plot (C) showing the
neutrophil infiltrate score for those animals that were homozygous
for founder strain alleles at HrI4 (A/J = yellow, C57BL/6J = grey,
129S1/SvImJ= pink, NOD/ShiLtJ = dk. blue, NZO/HILtJ = lt.
blue, CAST/EiJ = green, PWK/PhJ = red, WSB/EiJ = purple).
(TIF)
Table S1 Mean (range) of IAV associated phenotypes
comparing founder strains and the Pre-CC.
(DOCX)
Table S2 Phenotypic correlations across the pre-CC
population.
(DOCX)
Table S3 Significance of predictors of D4 weight.
(DOCX)
Table S4 Transcripts within expression modules.
(DOCX)
Table S5 GO-term enrichment by module.
(DOCX)
Table S6 Mx1 sequence variants.
(DOCX)
Table S7 Transcripts with an eQTL at Mx1.
(DOCX)
Table S8 GO-Term enrichment of eQTL that differen-
tiate the CAST/EiJ Mx1 allele’s effects.
(DOCX)
Table S9 Phenotypic mean (ranges) between entire pre-
CC population and the Mx1-/- subpopulation.
(DOCX)
Table S10 Phenotypic correlations across the Mx1-/-
pre-CC subpopulation.
(DOCX)
Table S11 Transcripts within modules in the Mx1-/-
subpopulation.
(DOCX)
Table S12 GO-term enrichment by module in Mx1-/-
subpopulation.
(DOCX)
Table S13 Transcriptional module correlates with in-
fluenza phenotypes in the Mx1-/- subpopulation.
(DOCX)
Table S14 Primers used in sequencing Mx1.
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